Invesaro

Stocks Comparison

Aspen Aerogels vs QXO: revenue, profit, margins and growth compared

Aspen Aerogels brought in $271.1M of revenue in fiscal 2025, QXO $6.8B in fiscal 2025. Revenue changed by -40.1% at Aspen Aerogels and +11,925.0% at QXO on the year before, so QXO grew faster. Aspen Aerogels kept -143.7% of its revenue as net profit, QXO -4.1%. Free cash flow was -$4.6M at Aspen Aerogels and $183.2M at QXO.

Side by side, latest fiscal year

ASPNQXO
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$271.1M$6.8B
Revenue growth-40.1%+11,925.0%
Net income-$389.6M-$279.4M
Net margin-143.7%-4.1%
Free cash flow-$4.6M$183.2M
Free cash flow margin-1.7%2.7%
Earnings per share (diluted)-$4.73-$0.63
Cash$156.9M$2.4B
Debt$65.5M$3.1B
Price to earningsn/an/a
Market value$433.2M$12.9B
Dividend yieldn/an/a
Rank by revenue in sector#630 of 778 · Consumer discretionary#158 of 778 · Consumer discretionary

Over the years

Revenue
ASPN FY2018: $104.4MASPN FY2019: $139.4MASPN FY2020: $100.3MASPN FY2021: $121.6MASPN FY2022: $180.4MASPN FY2023: $238.7MASPN FY2024: $452.7MASPN FY2025: $271.1MQXO FY2018: $36.1MQXO FY2019: $38.5MQXO FY2020: $41.2MQXO FY2021: $41.7MQXO FY2023: $45MQXO FY2023: $54.5MQXO FY2024: $56.9MQXO FY2025: $6.8BFY18FY19FY20FY21FY22FY23FY24FY25
ASPN $271.1MQXO $6.8B
Net income
ASPN FY2018: -$34.4MASPN FY2019: -$14.6MASPN FY2020: -$21.8MASPN FY2021: -$37.1MASPN FY2022: -$82.7MASPN FY2023: -$45.8MASPN FY2024: $13.4MASPN FY2025: -$389.6MQXO FY2018: $262.4KQXO FY2019: $6.8MQXO FY2020: $175.6KQXO FY2021: -$134.4KQXO FY2023: -$282.2KQXO FY2023: -$1.1MQXO FY2024: $28MQXO FY2025: -$279.4MFY18FY19FY20FY21FY22FY23FY24FY25
ASPN -$389.6MQXO -$279.4M
Net margin
ASPN FY2018: -33.0%ASPN FY2019: -10.5%ASPN FY2020: -21.7%ASPN FY2021: -30.5%ASPN FY2022: -45.9%ASPN FY2023: -19.2%ASPN FY2024: 3.0%ASPN FY2025: -143.7%QXO FY2018: 0.7%QXO FY2019: 17.6%QXO FY2020: 0.4%QXO FY2021: -0.3%QXO FY2023: -0.6%QXO FY2023: -2.0%QXO FY2024: 49.2%QXO FY2025: -4.1%FY18FY19FY20FY21FY22FY23FY24FY25
ASPN -143.7%QXO -4.1%
Revenue growth
ASPN FY2019: +33.6%ASPN FY2020: -28.1%ASPN FY2021: +21.3%ASPN FY2022: +48.3%ASPN FY2023: +32.4%ASPN FY2024: +89.6%ASPN FY2025: -40.1%QXO FY2019: +6.6%QXO FY2020: +7.1%QXO FY2021: +1.2%QXO FY2023: +7.9%QXO FY2023: +21.2%QXO FY2024: +4.4%QXO FY2025: +11,925.0%FY19FY20FY21FY22FY23FY24FY25
ASPN -40.1%QXO +11,925.0%
Free cash flow
ASPN FY2018: -$12.2MASPN FY2019: -$3.2MASPN FY2020: -$13.3MASPN FY2021: -$32.4MASPN FY2022: -$272.4MASPN FY2023: -$218.1MASPN FY2024: -$40.7MASPN FY2025: -$4.6MQXO FY2018: $1.1MQXO FY2019: -$974KQXO FY2020: $1.6MQXO FY2021: $111.3KQXO FY2023: $2MQXO FY2023: $463KQXO FY2024: $84.7MQXO FY2025: $183.2MFY18FY19FY20FY21FY22FY23FY24FY25
ASPN -$4.6MQXO $183.2M

Fiscal years as each company reports them; the two may end in different months.

Questions about Aspen Aerogels and QXO

Which is bigger by revenue, Aspen Aerogels or QXO?

QXO is bigger by revenue: $6.8B in fiscal 2025, against $271.1M for Aspen Aerogels in fiscal 2025.

Which keeps more of its revenue as profit, Aspen Aerogels or QXO?

Aspen Aerogels had a net margin of -143.7% in fiscal 2025; QXO had -4.1% in fiscal 2025.

Which grew revenue faster, Aspen Aerogels or QXO?

In their latest fiscal years revenue changed by -40.1% at Aspen Aerogels and +11,925.0% at QXO.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies